This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Conaris Research Institute. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Jørgen Wittendorff: Innovator in Extended Release Formulations
Introduction
Jørgen Wittendorff is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of extended release technologies.
Latest Patents
Wittendorff holds a patent for an "Extended release nicotinamide formulation." This invention provides various extended release granules of nicotinamide, which can be enhanced by the inclusion of a conductive filler. His innovative approach aims to improve the delivery and efficacy of nicotinamide in therapeutic applications.
Career Highlights
Jørgen Wittendorff is associated with Conaris Research Institute AG, where he continues to explore advancements in pharmaceutical formulations. His work has been instrumental in developing new methods that enhance drug delivery systems.
Collaborations
Wittendorff collaborates with Bent Højgaard, contributing to the research and development efforts at Conaris Research Institute AG. Their partnership focuses on innovative solutions in the pharmaceutical industry.
Conclusion
Jørgen Wittendorff's contributions to extended release formulations highlight his role as a key innovator in the pharmaceutical field. His work continues to influence the development of effective drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile